Alpha-GPC

non-nutrient_non-botanical
View products

Alpha-GPC is a highly bioavailable form of choline, an essential nutrient important for various bodily functions. In the brain, Alpha-GPC crosses the blood-brain barrier and serves as a precursor to acetylcholine, a neurotransmitter involved in memory, learning, and overall cognitive processing. This mechanism is thought to contribute to its cognitive-enhancing effects. Beyond its cognitive roles, Alpha-GPC is researched for its impact on physical performance. It may help increase power output and strength by supporting neuromuscular function and healthy growth hormone secretion. This makes it a frequent choice for those looking to optimize their physical capabilities. As a non-botanical compound, Alpha-GPC is common in supplements designed to improve focus and exercise performance. Research continues into its efficacy and safety, with a generally good safety profile when used appropriately.

Natural sources
SoybeansEggsMeatFishDairy products

No public comparison lists found.

Optimal Dosage
Minimum300 mg
Maximum600 mg
Safety & Toxicity
Toxicity Threshold1200 mg
Toxicity EffectHeadache, dizziness
4 safety notes
  • Pregnant or nursing women should consult a healthcare professional before use.
  • Individuals with pre-existing medical conditions should consult a doctor before taking Alpha-GPC.
  • May cause gastrointestinal discomfort in some individuals.
  • Avoid exceeding recommended dosages.
Goals
Brain Health
Brain Health
Impact
High effect
Typical dose:300–600 mg

Alpha-GPC efficiently crosses the blood-brain barrier to provide choline, a crucial building block for acetylcholine. This neurotransmitter is vital for learning, memory formation, and focus. Supplementation supports optimal cholinergic function, which can decline with age.

Focuses on
MemoryFocusBrain Protection
Most relevant for
Individuals managing age-related cognitive decline or seeking targeted support for neurotransmitter production.

Potential benefits

  • Support for Cognitive Decline.Meta-analyses and clinical trials show Alpha-GPC improves memory, behavior, and daily function in individuals with dementia or vascular-related cognitive impairment.
  • Neurotransmitter Support.It provides a bioavailable source of choline that efficiently crosses the blood-brain barrier to support the production of acetylcholine, a neurotransmitter vital for learning.
  • Acute Attention Performance.Research in healthy adults indicates that specific acute doses may improve performance on tasks requiring attention and mental focus.

Limitations

  • Clinical Population Focus.The most significant evidence for cognitive benefit is centered on patients with existing neurological conditions rather than healthy individuals.
  • Specific Task Constraints.In healthy populations, benefits appear limited to specific measures like attention and reaction time rather than overall cognitive enhancement.
  • Long-term Prevention Uncertainty.There is currently no established evidence that supplementation prevents the onset of dementia or provides long-term neuroprotection in the general population.

Study evidence

12 studies

Alpha-GPC may improve cognitive symptoms in people with dementia or other cognitive impairment. The available research is more supportive in these clinical settings than in healthy adults, where limited findings do not establish lasting brain-health benefits or prevention of decline.

View goal
Cognitive Support
Cognitive Support
Impact
High effect
Typical dose:300–1200 mg

Alpha-GPC is a highly bioavailable source of choline that readily crosses the blood-brain barrier. It supports the acetylcholine system, which is involved in memory and focus, and has acute cognitive effects.

Focuses on
MemoryFocusBrain Protection
Most relevant for
Older adults and those experiencing mild age-related memory or cognitive challenges who are seeking clinically studied support for mental performance.

Potential benefits

  • Improved Cognitive Scores.Alpha-GPC has been shown in multiple clinical trials to improve standardized test scores for memory, attention, and verbal fluency in individuals with mild-to-moderate cognitive impairment.
  • Enhanced Daily Functioning.Research indicates that regular use may support better functional and behavioral outcomes, helping individuals maintain independence in daily activities during cognitive decline.
  • Synergistic Medical Support.When used as an adjunct to certain dementia medications like donepezil, Alpha-GPC may provide additional cognitive and non-cognitive improvement compared to medication alone.

Limitations

  • No Impact on Disease Progression.Large-scale cohort data suggests that while Alpha-GPC may improve symptoms, it does not stop the underlying progression from mild cognitive impairment to all-cause dementia.
  • Uncertain Benefits for Healthy Adults.Most supportive evidence is derived from populations with existing neurological conditions or vascular injury; its effectiveness for cognitive enhancement in healthy young adults is not established.
  • Administration Differences.Some research demonstrating high efficacy utilized injected administration, which may not produce the same results as standard oral supplementation.
Things to consider

Individuals should not rely on this supplement to prevent the onset of Alzheimer's disease or dementia, as observational studies have shown no significant effect on disease conversion rates.

Study evidence

15 studies

Alpha-GPC has improved cognitive symptoms in some people with dementia or other cognitive impairments, including when added to medication. These findings do not establish sharper thinking in healthy people or show that Alpha-GPC prevents progression to dementia.

View goal
Longevity
Longevity
Impact
High effect
Typical dose:300–1200 mg

Alpha-GPC is a highly bioavailable form of choline that readily crosses the blood-brain barrier. It helps maintain the structural integrity of neuronal membranes and supports the synthesis of acetylcholine, a key neurotransmitter involved in cognitive processes. Supplementation can help counteract age-related declines in memory, focus, and mental acuity.

Focuses on
Brain Ageing
Most relevant for
Aging adults seeking to support cognitive performance and brain health through choline supplementation.

Potential benefits

  • Brain Health Support.Unconfirmed. Alpha-GPC is a source of choline which supports cognitive health, but its specific benefit for the goal of anti-aging remains unproven due to the absence of direct clinical research.
  • Cellular Integrity.Unconfirmed. It may help maintain neuronal membrane structure as one ages, though this anti-aging property is unconfirmed and lacks supporting evidence in the provided data.

Limitations

  • No Direct Research.There are no provided clinical studies to confirm that Alpha-GPC slows the biological aging process or influences longevity.
  • Scope of Evidence.Existing information focuses on choline delivery for cognitive function rather than establishing a broad anti-aging effect.

Study evidence

No published studies for this goal yet.

View goal
Mental Focus
Mental Focus
Impact
High effect
Typical dose:300–600 mg

Alpha-GPC readily crosses the blood-brain barrier to serve as a direct precursor for acetylcholine synthesis. This supports neuronal communication, enhances learning capacity, and can sharpen focus for cognitively demanding activities.

Focuses on
AttentionProcessing Speed
Most relevant for
Healthy, physically active adults seeking a short-term cognitive boost for tasks requiring high concentration.

Potential benefits

  • Selective Attention.May improve the ability to ignore distractions and stay focused on specific tasks during periods of physical or mental effort.
  • Processing Speed.Evidence suggests potential for faster reaction times and improved accuracy on concentration-heavy tasks shortly after use.

Limitations

  • Inconsistent Outcomes.Improvements were seen in selective attention but not in other areas like working memory or inhibitory control.
  • Participant Constraints.Study results are based on a small group of resistance-trained men, so effects on the general population are not well-established.
  • Short-Term Data.Research demonstrates immediate effects only; there is no evidence that long-term use provides a cumulative benefit for mental focus.

Study evidence

1 study

Alpha-GPC may briefly improve some aspects of attention in healthy, physically trained men, but the evidence is preliminary. Benefits were limited to selected cognitive tasks, so better everyday focus or a lasting improvement in mental performance is not established.

View goal
Productivity Boost
Productivity Boost
Impact
High effect
Typical dose:300–1200 mg

Acetylcholine is essential for learning, memory recall, and concentration. Alpha-GPC efficiently delivers choline to the brain, providing the raw material needed to produce this key neurotransmitter, thereby supporting overall cognitive horsepower and mental clarity.

Focuses on
AlertnessProcessing SpeedBrain Nutrients
Most relevant for
Healthy adults seeking a short-term increase in mental focus and attention for specific cognitive tasks.

Potential benefits

  • Enhanced Selective Attention.Evidence indicates that acute supplementation may improve focus and accuracy on tasks requiring the filtering of distracting information.
  • Faster Mental Processing.Short-term use has been associated with reduced completion times on certain cognitive assessments, suggesting a temporary boost in mental agility.
  • Real-World Productivity.Unconfirmed. While specific cognitive metrics may improve in a lab setting, a direct benefit to overall daily productivity or task completion is unproven and not yet established.

Limitations

  • Selective Cognitive Impact.Observed benefits appear limited to specific attention tasks and do not consistently extend to working memory or general alertness.
  • Short-Term Evidence.Research primarily evaluates the immediate effects following a single dose rather than sustained productivity over a workday or long-term use.
  • Specific Study Populations.Key findings for healthy individuals are currently based on small groups of young, active men, making the effects on the broader population uncertain.

Study evidence

2 studies

Alpha-GPC may improve some aspects of attention on cognitive tests, but the available evidence does not establish a productivity boost. Results in healthy men were selective, with no clear improvement in working memory or attention across all tests.

View goal
Mood Support
Mood Support
Impact
Situational effect
Typical dose:300–600 mg

Alpha-GPC readily crosses the blood-brain barrier to provide choline for the synthesis of phosphatidylcholine, a key component of neuronal membranes, and acetylcholine, a neurotransmitter involved in memory and mood. Healthy cell membranes are crucial for proper neurotransmitter signaling.

Focuses on
Mood ChemistryBrain Nutrients
Most relevant for
Individuals with Alzheimer's disease using donepezil who are looking to manage related mood symptoms.

Potential benefits

  • Mood in Cognitive Decline.Alpha-GPC may help reduce depressive symptoms in mild-to-moderate Alzheimer's cases when used alongside the medication donepezil.
  • Everyday Mood Support.Unconfirmed. The benefit for general mood support in healthy individuals is unproven, as research has not evaluated Alpha-GPC alone for this purpose.

Limitations

  • Not a Standalone Treatment.Evidence is limited to use as an add-on therapy; there is no research showing mood benefits when Alpha-GPC is taken by itself.
  • Population Specificity.Findings are currently restricted to individuals with Alzheimer's disease and may not apply to the general population.
Things to consider

This supplement was studied at a dose of 1,200 mg per day in a clinical setting alongside prescription medication.

Study evidence

1 study

Alpha-GPC has limited evidence for mood support when added to donepezil in people with Alzheimer's disease. Depressive symptoms improved in that treatment setting, but the available research does not establish a mood benefit from Alpha-GPC alone or in otherwise healthy people.

View goal
Showing 6 of 7 goals

Studies

Research connections will load here.
Sources

Up to five highest-ranked published examples per goal. Study counts and charts include all published studies for the connection.

  1. Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
    Sagaro GG; Traini E; Amenta F · Journal of Alzheimer's disease : JAD · 2023
    Meta-analysis8 studies pooledBrain HealthCognitive Support
  2. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M · Medicine · 2024
    Randomized trial119 participantsCognitive SupportBrain Health
  3. Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
    Sohn M; Park YH; Lim S · Diabetes, obesity & metabolism · 2025
    Randomized trial36 participantsBrain HealthCognitive Support
  4. Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
    Kerksick CM · Nutrients · 2024
    Randomized trial20 participantsBrain HealthProductivity BoostMental Focus
  5. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M · Clinical therapeutics · 2003
    Randomized trial261 participantsBrain Health
  6. [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
    Voznyuk IA; Nepomnyashchiy IS; Kutkova AK; Tokareva DV; Prokhorova MV; Ovdiienko OA; Shusharina NN · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2025
    Meta-analysis10 studies pooledCognitive Support
  7. Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
    Guan F; Jia X; Huang F; Zhang J; Wei Y; Li L; Bai J; Wang H · Nutrients · 2024
    Cohort study7,659 participantsCognitive Support
  8. Treatment of dementia with neurotransmission modulation.
    Doggrell SA; Evans S · Expert opinion on investigational drugs · 2004
    Narrative reviewProductivity Boost
  9. Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer's Disease
    Anna Carotenuto, Angiola Maria Fasanaro, Valentino Manzo, Francesco Amenta, Enea Traini · Journal of Alzheimer's disease reports · 2022
    Randomized trial90 participantsMood Support
  10. The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength
    David Bellar, Nina R LeBlanc, Brian Campbell · Journal of the International Society of Sports Nutrition · 2015
    Randomized trial13 participantsMuscle Gain